Subscribe To
Ultragenyx to Participate in the Goldman Sachs 44th Annual Global Healthcare Conference
NOVATO, Calif., June 07, 2023 (GLOBE NEWSWIRE) — Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for serious rare and ultrarare genetic diseases, today announced that Emil D. Kakkis, M.D., Ph.D., the company’s chief executive officer and president, will participate in a fireside at the upcoming […] The post Ultragenyx to Participate in the Goldman Sachs 44th Annual Global Healthcare Conference appeared...
Read More
Posted: Jun 7 2023, 21:00
Author Name: forextv
Views: 081247